Publications for the month of July 2020
The Department had nine publications listed in PubMed for the month of July 2020.
1: Arenas A, Chen J, Kuang L, Barnett KR, Kasarskis EJ, Gal J, Zhu H. Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS. Hum Mol Genet. 2020 Jul 21:ddaa159. doi: 10.1093/hmg/ddaa159. Epub ahead of print. PMID: 32691043.
2: Eleazer R, Fondufe-Mittendorf YN. The multifaceted role of PARP1 in RNA biogenesis. Wiley Interdiscip Rev RNA. 2020 Jul 12:e12607. doi: 10.1002/wrna.1617. Epub ahead of print. PMID: 32656996.
Sanders-Brown Researchers Publish Article Exploring if ‘Social Distancing’ Will Lead to ‘Research Distancing’
UK Cardiologist Selected for Mentoring Award
LEXINGTON, Ky. (Aug. 5, 2020) — Dr. Gretchen Wells, director of the UK HealthCare (UKHC) Women's Heart Program at the Gill Heart & Vascular Institute, has been selected to receive the American Heart Association's Council on Clinical Cardiology 2020 Women in Cardiology Mentoring Award.
The award is designed to recognize individuals who have an outstanding record of effectively mentoring women cardiologists and underscores the importance of mentoring in the professional development of women.
Kuhs Named Co-Leader of Markey Cancer Prevention & Control Research Program
LEXINGTON, Ky. (Aug. 4, 2020) – The University of Kentucky Markey Cancer Center has announced that Krystle Kuhs, Ph.D., M.P.H., will serve as co-leader of its Cancer Prevention and Control Research Program. Kuhs will co-lead the program with University of Kentucky College of Public Health Associate Professor Jerod Stapleton, Ph.D., who joined the university in November 2019.
Volunteers Needed for Survey on Sleep, Stress, Alcohol Use During COVID-19 Outbreak
UK Surgeons, Engineer Collaborate on Medical Tech Design
Lexington, Ky. (July 31, 2020) – During a routine surgery that combined their specialties, Dr. Mark Fritz, a laryngologist in the University of Kentucky Department of Otolaryngology, and Dr.
How a Chance Encounter – and COVID-19 – Brought this Michigan Resident to Markey
LEXINGTON, Ky. (July 31, 2020) – During his chemotherapy treatments, Scott Storey got used to avoiding cold drinks and foods. The regimen he was on, FOLFOX, includes the drug oxaliplatin, which is known to cause “cold dysesthesia” in some patients. It’s a hypersensitivity to the presence of cold that can trigger side effects such as peripheral neuropathy, jaw spasms, shortness of breath and more.
This peculiar fact – and a serendipitous meeting with a stranger – proved to be a lifeline for the retired Air Force veteran.
CHET Statement on Racism
Racism is a public health threat that undermines health equity. We re-commit to our anti-racist research and training mission and collectively maintain that the egregious injustices perpetrated against Black people--historical and current-did not arise nor will they cease overnight. We have been working to raise the visibility of the goal of health equity through numerous other means-- our training, research, and community outreach.
You can read our full statement at the link below.
Important Dementia Studies Continuing at UK Despite Ongoing COVID-19 Pandemic
LEXINGTON, Ky. (July 30, 2020) —The COVID-19 pandemic brought many things to a screeching halt and continues to impact our daily lives. However, important research at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) is continuing under extreme caution and deep dedication.
“It can’t wait,” said Dr. Greg Jicha, a neurologist at SBCoA.